MACQUARIE GROUP LTD - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,000
+100.0%
0
-100.0%
0.00%
Q2 2022$2,000
-33.3%
1160.0%0.00%
Q1 2022$3,0000.0%1160.0%0.00%
Q4 2021$3,0000.0%1160.0%0.00%
Q3 2021$3,000
-25.0%
1160.0%0.00%
Q2 2021$4,0000.0%1160.0%0.00%
Q1 2021$4,000
-20.0%
116
-32.2%
0.00%
Q4 2020$5,000
-16.7%
1710.0%0.00%
Q3 2020$6,000
-25.0%
1710.0%0.00%
Q2 2020$8,000
-91.8%
171
-94.1%
0.00%
Q1 2020$98,0002,8760.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders